Market Research Logo

Global Contraceptive Devices Market - Segmented by Type, Gender, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Global Contraceptive Devices Market - Segmented by Type, Gender, and Geography - Growth, Trends, and Forecast (2018 - 2023)

The global contraceptive devices market was valued at around USD 20 billion in 2017 and is projected to register a CAGR of approximately 7% during the forecast period 2018–2023. China, the world’s most populated country, with a population of around 1.36 billion, has one of the highest rates of contraceptives usage.

Government Initiatives to Prevent Unwanted Abortions and Pregnancies

Unwanted pregnancies are on the rise, globally. Government bodies of various countries have been taking measures, like promoting the use of contraceptive devices to prevent this unwanted growth. It is estimated that among the number of pregnancies that occur in the United States, nearly 76% of them are unwanted, and are under the age of 30. According to Harvard researchers, it is estimated that single parenthood due to unwanted pregnancies is the reason for holding out on economic mobility, more than other variables like education and race. Given the widespread implications of unwanted pregnancies, the market for contraceptive devices is expected to experience a surge during the forecast period. Also, other factors, like the increasing incidence of STDs and the rapid increase in population, will accelerate the growth of the contraceptive devices market.

Limited Access to Contraception

Access to safe, voluntary family planning is a human right. Family planning is central to gender equality and women’s empowerment and is a key factor in reducing poverty. Millions of women are unable to prevent unwanted pregnancies, which is impacting their lifestyle, as well as that of the child, both economically and socially. This is happening primarily due to the lack of knowledge and limited access to contraception and is more prevalent among low and middle-income nations of the world. An estimated 69 countries face the problem of limited access to contraception. Lack of awareness and limited supply has been one of the major reasons for the contraceptive devices market’s limited growth in the developing nations. Apart from these, the high cost of conventional contraceptive devices, like intra-uterine device (IUD), is also acting as a barrier to the growth of the market.

United States Holds the Largest Market Share

There were approximately 60 million women in the United States in their child-bearing years (age 15 – 44), as of 2017. Around 70% of these women were at risk of unintended pregnancy. More than 99% of women aged between 15 - 44 years have used at least one contraceptive method. This indicates the high awareness and demand for avoiding unintended pregnancies in the United States. The use of contraceptive devices accounts for the second largest expenditure on contraceptive methods in the United States, and globally alike.

Key Developments in the Market

  • November 2017: Teva Pharmaceuticals has signed an agreement with CooperSurgical to acquire PARAGARD® (an intrauterine copper contraceptive product).
  • July 2017: Teva Pharmaceutical has announced the launch of Vagifem®1 (estradiol vaginal inserts), 10 mcg in the United States.

Reasons to Purchase the Report
  • To understand the current and future contraceptive devices market in the developed and emerging markets.
  • Analyzing various perspectives of the market with the help of Porter’s Five Forces Analysis.
  • Identify the segment that is expected to dominate the market.
  • Identify the regions that are expected to witness the fastest growth during the forecast period.
  • Identify the latest developments, market shares, and strategies employed by the major market players.
  • 3 month analyst support along with the Market Estimate sheet (in Excel).
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Drivers
6.1.1 Product Innovation
6.1.2 Increasing Incidence of STDs
6.1.3 Rise in Government Initiatives to Prevent Unwanted Abortions and Pregnancies
6.2 Restraints
6.2.1 Cultural or Religious Opposition
6.2.2 Limited Access to Contraception
6.2.3 Infertility Issues
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Type
7.1.1 Condoms
7.1.2 Diaphragms
7.1.3 Cervical Caps
7.1.4 Sponges
7.1.5 Vaginal Rings
7.1.6 Intra Uterine Devices
7.1.7 Implants
7.2 By Gender
7.2.1 Male
7.2.2 Female
7.3 By Geography
7.3.1 North America United States Canada Mexico Rest of North America
7.3.2 Europe United Kingdom Germany France Italy Spain Rest of Europe
7.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
7.3.4 Middle East & Africa Gcc South Africa Rest of the Middle East & Africa
7.3.5 South America Brazil Argentina Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Product Launches
9. Key Players
9.1 Actavis PLC
9.2 Agile Therapeutics
9.3 Bayer Healthcare
9.4 Fuji Latex Co. Ltd
9.5 Johnson & Johnson
9.6 Lupin Pharmaceuticals
9.7 Merck & Co.
9.8 Pfizer
9.9 Reckitt Benckiser Group PLC
9.10 Teva Pharmaceuticals
9.11 The Female Health Company
9.12 Others
10. Future of the Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report